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Abstract 
Social anxiety disorder (SAD) is one of the most common comorbid conditions in eating 
disorders (EDs). The aim of the current review and meta-analysis is to provide a qualitative 
summary of what is known about social anxiety (SA) in EDs, as well as to compare levels of 
SA in those with EDs and healthy controls (HCs). Electronic databases were systematically 
searched for studies using self-report measures of SA in ED populations. In total, 38 studies 
were identified, 12 of which were included in the meta-analyses. For both anorexia nervosa 
(AN) and bulimia nervosa (BN), there were significant differences between ED groups and 
HCs, with medium to large effect sizes. Findings from the qualitative review indicate that 
levels of SA are similar across the ED diagnoses, and SA improves with treatment in AN. In 
addition, high levels of SA are associated with more severe ED psychopathology, but not 
BMI. These findings add to the wider literature on socio-emotional functioning in EDs, and 
may have implications for treatment strategies.  
  
Introduction 
Eating disorders (EDs) are associated with high levels of psychiatric comorbidity (Blinder et 
al. 2006); a factor linked to poorer short- and long-term outcomes (Berkman et al. 2007; Vall 
& Wade, 2015). Anxiety disorders are common, with a lifetime prevalence of around 60% 
reported in both anorexia nervosa (AN) and bulimia nervosa (BN) (Bulik et al. 1997). In 
particular, social anxiety disorder (SAD; also known as social phobia) is consistently found 
to be the first or second most common comorbid anxiety disorder in EDs (Godart et al. 2000; 
Kaye et al. 2004; Swinbourne et al. 2012), with prevalence rates ranging from 16% to 88.2% 
in AN and 17% to 67.8% in BN (Swinbourne & Touyz, 2007). In comparison, lifetime 
prevalence of SAD in the general population is around 12% (Kessler et al. 2005). The 
association between SAD and EDs is also replicated in non-clinical populations, where 
disordered eating is positively associated with social anxiety (SA) levels (Gilbert & Meyer, 
2003; Gadalla & Piran, 2008; Utschig et al. 2010; Ciarma & Mathew, 2017). High levels of 
SA in EDs may be part of a wider socio-emotional phenotype hypothesised to contribute to 
the development and maintenance of EDs (Treasure & Schmidt, 2013). For example, people 
with AN report having impoverished social networks and internalising problems in 
childhood, problems which are further accentuated by the ill state (Adambegan et al. 2012; 
Harrison et al. 2014; Westwood et al. 2016). Similarly, adolescents and young adults with 
ED show more insecure attachment styles (Dias et al. 2011), which are theorised to have 
lasting implications on emotion regulation, social processing, and self-evaluative processes 
(Gander et al. 2015).  
Explanations for the link between EDs and SA have been proposed. Firstly, SA may be a risk 
factor for the development of an ED. For example, anxiety around how oneself appears to 
others may lead to an excessive interest in body weight and shape (Godart et al. 2000). 
Another possibility is that SA may be secondary to the ED, as a consequence of ED 
psychopathology or malnutrition. Studies examining the temporal relations between the two 
disorders lend some support to the former hypothesis, where it is consistently reported that 
SAD onset preceded the ED in the majority of those with both disorders (Bulik et al. 1997; 
Godart et al. 2000; Kaye et al. 2004; Swinbourne et al. 2012). However, such studies rely on 
retrospective accounts of age of onset, and are therefore subject to recall biases. Two 
prospective studies using representative samples provide conflicting results, and suggest that 
the relationship with SAD may differ as a function of ED diagnosis. Buckner et al. (2010) 
found that BN in adolescence significantly increased the risk of both SAD and panic disorder 
in adulthood, however no anxiety or depressive disorder in adolescence predicted later BN. 
AN in adolescence did not increase the risk of any anxiety disorder or depression in 
adulthood, but adolescent obsessive compulsive disorder (OCD) predicted the development 
of AN in adulthood. In contrast, Ranta et al. (2017) found that both SAD and depression at 
age 15 predicted BN at age 17, however the relationship between SAD and BN was not 
significant after controlling for depression. Contrary to the previous study, neither AN or BN 
predicted later SAD, however this may be due to the far shorter follow-up period. Thus, 
evidence regarding the direction of causality is inconsistent.  
A final explanation for the comorbidity is that SAD may share common vulnerability factors 
with ED, as has been found to be the case with OCD. In addition to AN being more common 
in probands of individuals with OCD (an effect that increases with degree of genetic 
relatedness), moderate genetic overlap between the two disorders has been reported in a large 
population-based twin sample (Cederlӧf et al. 2015). Similarly, SAD occurs at significantly 
higher rates in first-degree relatives of probands with AN than those of healthy controls 
(HCs) (Strober et al. 2007). It may be that heritable vulnerability factors such as 
perfectionism partly explain the genetic overlap between anxiety disorders and EDs. For 
example, perfectionism, a trait that is elevated in both individuals with EDs and those with 
SAD (Antony et al. 1998; Lloyd et al. 2014) has been found to predict both SA and 
disordered eating in non-clinical women (Levinson & Rodebaugh, 2016). Perfectionism has 
also been shown to moderate the relationship between SA and bulimic symptoms 
specifically, where those with high SA and perfectionism showed the most bulimic symptoms 
(Silgado et al. 2010). Due to a lack of research on common vulnerability factors in clinical 
ED and SAD populations, no firm conclusions for the high levels of comorbidity can be 
drawn.  
To date, only one review has examined comorbidity between EDs and SAD, within a general 
review of anxiety disorder comorbidity in EDs (Swinbourne & Touyz, 2007). However, this 
review (a) only provided categorical prevalence estimates of anxiety disorders in ED 
populations, and (b) did not examine whether SA differs across ED sub-types. Further, new 
studies have become available. Therefore, the aim of the current review and meta-analysis is 
to compare SA in EDs compared to HCs, and provide a qualitative synthesis of the literature, 
e.g., differences in SA between ED sub-types, the effects of treatment on SA, and 
associations between SA and factors such as body mass index (BMI) and ED 
psychopathology.  
Method 
The review and meta-analysis was conducted using the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) statement (Liberati et al. 2009).  
Eligibility criteria  
Studies using a quantitative measure of SA were included in the review. Inclusion criteria 
were: 1) at least one clinical ED sample; 2) means and standard deviations reported; 3) full 
article available in English; 4) published in a peer-reviewed journal. Studies measuring only 
related constructs (e.g., “secondary social phobia”, “social appearance anxiety”) were not 
included.  
Information sources and search 
The electronic databases PubMed, PsycInfo, SCOPUS, and Web of Science were searched 
independently by JKG and AH for papers up to February 2018. Search terms included social 
anxiety OR social phobia AND anorexia nervosa OR bulimia nervosa OR eating disorder OR 
binge eating disorder. No search limits were applied, except for in Web of Science, where 
results were filtered by the ED term for relevance.  
Study selection 
Screening and selection of articles is displayed in Figure 1. Where titles of papers appeared 
relevant, abstracts were screened to check eligibility. Full texts of potentially eligible studies 
were then retrieved. Studies that met all eligibility criteria but did not include a HC group 
were included in the qualitative review, whereas those that included a HC group were 
included in both the meta-analysis and the qualitative review. Where a study did not report 
means and standard deviations for SA scores, study authors were contacted. When no 
response was received, studies were excluded.  
Data collection 
The following information was extracted from each paper: number of participants in each 
group, diagnosis, mean SA score, SA measure used, age, BMI, illness duration, percentage of 
female participants, group matching technique, and recruitment source.  
Risk of bias in individual studies  
Risk of bias in individual studies was assessed by considering how certain methodological 
characteristics (participant recruitment source, group matching technique, and SA measure 
used) might have impacted the results of the studies.  
Summary measure & data synthesis 
The principle summary measure used in the meta-analysis was the difference in means and 
standard deviations for SA scores between ED and HCs. The meta-analyses were performed 
by pooling standardised effect sizes using a random effects model. Separate meta-analyses 
were performed for each ED sub-type, and studies that included more than one ED group 
(e.g., AN and BN) compared to HCs were included in each of the respective meta-analyses.  
Statistical analysis 
All analyses were performed using RStudio (R Core Team, 2017) using the metafor package 
(Viechtbauer, 2010). Cohen’s d was used to estimate effect sizes and is reported with 95% 
confidence intervals (CIs). Effect sizes are interpreted using Cohen’s (1988) definitions of 
small (0.2), medium (0.5), and large (0.8). Positive effect sizes indicate that the ED group had 
SA scores than HCs. Two AN studies included in the meta-analysis shared the same HC 
group, therefore a multivariate meta-analysis was conducted using the rma.mv command. 
Between study heterogeneity was calculated using Cochran’s Q test. Where heterogeneity 
was found (p < .05), meta-regressions were performed using age and SA measure as 
moderators. BMI could not be used as a moderator due to missing data.  
Risk of bias across studies 
The presence of publication bias was assessed through visual inspection of funnel plots, 
where the absence of studies in the bottom right corner indicates publication bias. Symmetry 
of the funnel plots were formally assessed using Begg’s rank correlation test (Begg & 
Mazumdar, 1994). Publication bias was also assessed using Rosenthal’s fail-safe N 
(Rosenthal, 1979), which estimates the number of unpublished studies required to change the 
significant effect size into a non-significant one.  
Results 
Study selection  
Thirty-eight studies were included in the review (Table 1). Studies that used the same sample 
(Duclos et al. 2014 and Courty et al. 2015; Hinrichsen et al. 2004a, 2004b, and 2007a)  are 
combined and the data considered together. Fourteen studies included a HC group, however 
two could not be included in a meta-analysis and are discussed in the qualitative review. Of 
the 12 studies that could be included, ten included an AN group and five included a BN 
group. One of the BN studies reported scores for males and females separately (Gross et al. 
1988), however males could not be included in the meta-analysis due to too few cases. Only 
one of the studies included in the meta-analysis provided mean SA scores for the different 
AN sub-types, therefore meta-analyses by sub-type could not be performed.  
Study characteristics 
Overall, reporting of study characteristics varied considerably. All studies provided 
information on the SA measure used, and in total, 12 different self-report questionnaires were 
used to measure SA. The most frequently used (n = 11) was the Liebowitz Social Anxiety 
Scale (LSAS; Liebowitz, 1987).  
Studies included in the meta-analysis and qualitative review 
Two of the 12 studies did not report the mean age of participants. Nine studies did not report 
the mean BMI or percentage of Ideal Body Weight (IBW) in at least one participant group, 
and 10 studies did not report mean illness duration of the ED group. Most studies only 
included female participants, however two studies included a small proportion of males in 
their ED group, and six included males in their HC group. Two studies did not report 
participants’ gender in at least one group. ED groups were most often inpatients (n = 6). 
Three studies did not report the recruitment source for their control group, and one did not 
report this information for the ED group. Groups were matched on some characteristic in 
eight of the studies, most often sex.  
Studies included in the qualitative review 
All 26 studies reported the mean age of participants. Four studies did not report mean BMI or 
percentage IBW in at least one participant group, and half did not report mean illness 
duration. Again, most studies included exclusively female participants, however six studies 
included males. One study did not report participants’ gender. ED groups were most often 
recruited from inpatient services (n = 8), but specialist ED or psychiatric services where it 
was ambiguous as to whether patients were outpatients or inpatients were also common (n = 
7). In studies where SA was compared between groups (n = 13), groups were most often 
matched by sex (n = 8), however five studies did not report a group matching technique. 
Synthesis of results & risk of bias 
The random-effects model with a total sample size of 1859 participants (AN = 281, HC = 
1578) revealed that those with AN had significantly higher levels of SA than HCs, with a 
large effect size (d = 1.65, [95% CI 1.03, 2.27] z = 5.20, p  <.001) (Figure 2). The funnel plot 
for the AN studies is displayed in Figure 3. There was no evidence of publication bias 
(Begg’s test p = .216, Rosenthal’s fail-safe N = 1033).   
The random-effects model with a total sample size of 1031 participants (BN = 232, HC = 
799) showed that those with BN had significantly higher levels of SA than HCs, with a 
medium effect size (d = 0.71, [95% CI 0.47, 0.95] z = 5.74, p <.001) (Figure 4). The funnel 
plot for the BN studies is displayed in Figure 5. There was no evidence of publication bias 
(Begg’s test p = .817, Rosenthal’s fail-safe N = 112).  
Additional Analyses  
There was evidence of significant heterogeneity in the AN studies Q(9) = 131.14, p <.001, 
therefore meta-regressions with age and SA measure as moderator variables were performed. 
BMI and illness duration could not be included as moderators due to studies not reporting this 
information. The moderators explained a significant amount of the variance, QM(4) = 32.56, 
p < .001. Age had a significant influence on the size of the effect (b = 0.12, [95% CI 0.03, 
0.21], z = 2.53, p = .01), as did using the LSAS as a measure of SA (b = 1.64, [95% CI 0.78, 
2.50], z = 3.73, p < .001). The test for residual heterogeneity was not significant, QE(4) = 
7.96, p = .09. There was no evidence of heterogeneity in the BN studies Q(3) = 0.67, p = .87.  
Qualitative Review 
Differences between ED and HC 
A few studies comparing ED groups to HCs could not be included in the meta-analysis due to 
there being too few comparisons. Otrovsky et al. (2013) examined SA scores in individuals 
with BED compared to overweight controls, finding that those with BED had significantly 
higher SA scores than controls. The second study examined SA scores in a mixed ED group 
compared to controls, finding that the ED group had significantly higher SA scores than HCs 
(Goddard & Treasure, 2013). This study also compared SA scores of parents of daughters 
with EDs to parents of HCs. Parents of daughters with EDs had higher SA scores than control 
parents, however effect sizes were small and not significant.  
Differences between ED diagnoses 
Of the seven studies that assessed differences between AN and BN, six found no difference 
in SA between groups (Bulik et al. 1991; Flament et al. 2001; Solano et al. 2005; Gilboa-
Schechtman et al. 2006; Grabhorn et al. 2006; Obeid et al. 2013). The single study that 
reported differences between ED groups found that individuals with AN-BP had significantly 
higher SA scores than AN-R and BN (Hinrichsen et al. 2003). Of the five studies that 
assessed differences between AN-R and AN-BP, four found no differences in SA across AN 
subtypes (Mattar et al. 2012a; Obeid et al. 2013; Duclos et al. 2014 and Courty et al. 2015; 
Abbate-Daga et al. 2015). As before, the single study that did find a difference was 
Hinrichsen et al. (2003).  
One study examined whether patients that met eating disorder not otherwise specified 
(EDNOS) criteria in the DSM-IV but BN criteria in the DSM-5 differed from patients who 
met DSM-IV criteria for BN (MacDonald et al. 2014). SA scores did not differ between 
groups. Finally, a study by Schwalberg et al. (1992) examined differences between BN and 
BED, finding that the groups did not differ in SA scores. Overall, it seems that SA is 
similarly elevated across ED diagnostic groups. 
Treatment effects and studies with recovered patients  
Six studies examined change in SA over treatment, two of which involved adolescent patients 
with AN admitted to inpatient care. Mattar et al. (2012b) assessed 24 patients at admission 
and discharge (mean time in treatment = 3.2 months), in which time mean SA scores 
significantly improved. Neither intensity of weight loss or BMI at admission, discharge, or 
improvements in BMI during treatment were correlated with SA scores. The second study 
(Courty et al. 2015) assessed 60 patients in the second half of their inpatient admission (21 
weeks on average). Patients were assessed at 6, 12, and 18 months. SA scores significantly 
decreased across time, with the largest reduction occurring between inclusion and 6-month 
follow-up. Further, SA levels were related to alexithymia across time, even after adjusting for 
depression, anxiety, and BMI.  
The third study in adolescents with AN followed 29 outpatients receiving group cognitive 
behavioural therapy (G-CBT), assessing psychiatric, social, and emotional variables before, 
during (3 and 6 months), at the end of (9 months), and one year after completing treatment 
(Ohmann et al. 2013). Patients were split into groups based on outcomes. It was found that 
SA significantly improved by 9 months in patients with a good outcome (defined as attaining 
25th BMI percentile and normal eating patterns), however SA did not improve in those with a 
poor or intermediate outcomes. Different from the aforementioned studies, the fourth 
treatment study (Abbate-Daga et al. 2015) examined 56 adult women with AN attending a 
day hospital service. The programme took a multidisciplinary approach with a focus on 
psychodynamic psychotherapy, and patients were assessed at baseline, end of treatment 
(EOT; 6 months), and at follow up, 12 months after EOT. Significant reductions in SA scores 
were seen at EOT and follow-up. Unlike the inpatient studies, neither of these studies 
examined whether decreases in SA were due to improvements in BMI.  
The final treatment study in AN was a randomised placebo-controlled trial examining the 
effects of intranasal oxytocin in 33 inpatients with AN (Russell et al. 2018). Contrary to 
predictions, there were no significant treatment, time, or treatment by time effects on SA 
scores, however EDE eating concern scores and cognitive rigidity were improved in the 
oxytocin group compared to placebo. The finding that SA scores did not improve over 
treatment in either group is at odds with the results of the former studies, however this might 
be due to the shorter follow up period (4-6 weeks). The final treatment study involved 29 
young adult women with BED, who were randomly assigned to a cognitive-behavioural 
intervention (“Appetite Awareness Training”) or a wait-list control group for 8 weeks (Allen 
& Craighead, 1999). It was found that SA scores reduced significantly in the intervention 
group compared to the control group. The intervention group also saw significant 
improvements in various measures of binge eating. 
Finally, one study examined differences in SA scores between women with acute AN, 
women recovered from AN, and HCs (Schmelkin et al. 2017). Women recovered from AN 
scored significantly higher than HCs, but significantly lower than acute AN on the social 
fear, public fear, and social avoidance sub-scales of the LSAS. However, on the public 
avoidance sub-scale, those with AN scored higher than HCs and recovered AN, who did not 
differ from one another. Thus, while it seems that SA significantly improves with treatment 
in AN, those recovered from the disorder still experience high levels of SA compared to HCs. 
It also appears that improvements in SA in AN are not related to a specific treatment 
modality, although further studies with control groups are required to confirm this finding. 
Associations with BMI 
Six studies examined whether SA was associated with BMI and other clinical indicators of 
ED severity. Two of these studies involved AN patients only, both finding that current BMI 
was not associated with SA scores in inpatient women (Matter et al. 2012a; 2012b). In 
addition, Mattar et al. (2012a) found that SA scores were negatively correlated with blood 
albumin levels (an indicator of nutritional status), and positively correlated with age and 
duration of illness. In a sample of women with AN or BN, Bulik et al. (1991) found no 
difference in SA scores when patients were split into underweight and normal weight groups. 
Similarly, in a mixed ED group (AN, BN, and EDNOS), SA was positively correlated with 
duration of illness and number of previous hospital admissions, but not current BMI 
(Goddard & Treasure, 2013). Further, those who were currently on medication had 
significantly higher SA than those not taking medication. Finally, in individuals with BED, 
higher SA was reported in those who became overweight as children, but was not correlated 
with current BMI (Sawaoka et al. 2012; Otrovsky et al. 2013). Thus, it seems that across the 
ED spectrum, SA is not related to BMI. Despite the lack of studies in this area, this finding 
suggests that high SA in those with EDs is not a result of malnutrition. Instead, those with a 
more severe illness may have higher levels of SA, as evidenced by the associations with 
longer duration of illness, more hospital admissions and medication use.  
Associations with psychopathology 
Consistent with the hypothesis that SA may be associated with a more severe illness, several 
studies have found positive associations between ED psychopathology and SA across the ED 
spectrum. In the same studies that found no association between SA and BMI in BED, 
significant positive relationships were found between SA and self-consciousness, depressive 
symptoms, Eating Disorder Examination (EDE) scores, weight, shape, and eating concerns, 
and binge eating severity (Sawaoka et al. 2012; Otrovsky et al. 2013). Similarly, in a mixed 
ED sample (AN, BN, or EDNOS), SA was significantly positively correlated with all eight 
Eating Disorder Inventory (EDI) subscales (drive for thinness, bulimia, body dissatisfaction, 
ineffectiveness, perfectionism, interpersonal distrust, interoceptive awareness, and maturity 
fears), as well as core beliefs about abandonment and emotional inhibition (Hinrichsen et al. 
2004a; 2004b; 2007a). This latter finding was partially replicated in a larger sample by 
Hinrichsen et al. (2007b), who found that core beliefs regarding abandonment and 
defectiveness/shame (the belief that one is fundamentally flawed) explained almost a quarter 
of the variance in SA. Further, another study using the EDI on a sample of children and 
adolescents with AN found SA scores were positively associated with ineffectiveness and 
interpersonal distrust subscales, as well as trait anxiety (Schulze et al. 2009).  
Two studies examined SA and psychopathological variables in adolescent mixed ED samples 
(AN, BN, and EDNOS). Buchholz et al. (2007) demonstrated that SA was a unique predictor 
of body dissatisfaction, and was also significantly positively associated with “self-silencing” 
(keeping negative thoughts or feelings to oneself), while Obeid et al. (2013) found a negative 
association between SA and self-esteem. Finally, one study found different results based on 
ED diagnosis. Hinrichsen et al. (2003) examined emotion coping strategies in women with 
EDs, reporting that while SA was associated with greater dissociation among those with AN-
R, this was not the case for those with AN-BP, BN, or HCs. Instead, higher levels of SA in 
BN and HC women were associated with higher bulimic psychopathology. Thus, it can be 
seen that SA in EDs is associated with not only more severe ED symptoms, but also beliefs 
and behaviours regarding self-esteem and emotion regulation.  
Associations with other comorbid symptoms  
Two studies assessed differences in SA between those with and without comorbid symptoms. 
Solano et al. (2005) examined differences between women with AN and BN who did and did 
not engage in self-injurious behaviour (SIB). Interestingly, while there was no effect of 
diagnosis on SIB, it was found that those who self-injured had significantly higher ED 
psychopathology, SA scores, and body image disturbance than those who did not. The second 
study examined differences in SA in women with BN, who either did or did not have a 
comorbid compulsive buying (CB) disorder (Jiménez-Murcia et al. 2015). CB is not currently 
recognised by international diagnostic classifications, but shares similarities with other 
impulse-related disorders such as BN and gambling disorder. It was found that SA scores 
were higher in women with both BN and CB, compared to those with BN only. However, 
after adjusting for age, this difference was no longer significant. Thus, although the results of 
Solano et al. (2005) suggest that high SA in EDs may be associated with more severe illness 
features such as self-harm, this might not be the case for addictive-type disorders. More 
research is required to clarify the possible transdiagnostic nature of SA in EDs and other 
disorders.  
Discussion 
The aim of this review was to examine group differences in SA in EDs compared to HCs, and 
provide a qualitative synthesis of the literature. There were significant differences in SA 
scores between both AN (10 studies) and BN (5 studies) compared to HCs, with large and 
medium effect sizes respectively, indicating that those with AN or BN have significantly 
higher levels of SA than HCs. Only one study compared levels of SA in BED compared to 
HCs, finding that SA was also significantly elevated in individuals with BED compared to 
HCs. While there was no evidence of publication bias in either meta-analysis, there was 
significant heterogeneity across AN studies. Meta-regressions with age and SA measure as 
moderator variables revealed that these variables explained a significant amount of the 
heterogeneity, such that use of the LSAS and older age of participants was associated with 
larger effect sizes. The association between the SA measure used by studies (namely the 
LSAS) and larger effect sizes has important implications for both research in this area and 
clinical practice. Self-report measures of SA have several advantages: they are quicker and 
easier to administer; and can provide an estimate of SA in those who do not meet full 
diagnostic criteria for SAD. However, the results from this meta-analysis suggest that SA in 
EDs may be over- or under-estimated, depending on the measure used. While cut-off scores 
on self-report measures have been established in groups with a diagnosis of SAD, there are 
outstanding questions regarding what can be considered a clinically significant level of SA in 
individuals with EDs. Identifying those with high SA may be useful when deciding on the 
type of treatment offered to patients. Further, while some scales measure SA 
unidimensionally, others provide sub-scores for different aspects of SA, such as fear, 
avoidance, and physiological arousal. Which of these types of measure would be most useful 
in ED populations is another question for future research. Physiological arousal as it relates to 
SA in EDs may be a particularly interesting domain to explore, given the reduced sensitivity 
to interoceptive signals reported in AN (Pollatos et al. 2008). 
The association between age and higher SA scores was also found in a few AN studies not 
included in the meta-analysis (Zonnevylle-Bender et al. 2004; Mattar et al. 2012a). One 
explanation for this finding is that those with a longer illness duration may experience higher 
levels of SA, in agreement with the results of Goddard and Treasure (2013). This may 
indicate a more severe illness, as suggested by the positive association between SA and ED 
psychopathology (Hinrichsen et al. 2003; 2004b; Schulz et al. 2009; Sawaoka et al. 2012; 
Otrovsky et al. 2013). This finding has important implications for understanding the 
etiological link between EDs and SA. From a developmental perspective, it has been 
postulated that there is a social phenotype for those at risk of developing an ED, characterised 
by loneliness, shyness, internalising problems, inferiority and low social support in childhood 
(Fairburn et al. 1999; Krug et al. 2013; Treasure & Schmidt, 2013). Indeed, SAD mostly 
occurs before ED onset in individuals diagnosed with both disorders (Bulik et al. 1997; 
Godart et al. 2000; Kaye et al. 2004; Swinbourne et al. 2012), and may be exacerbated by the 
ill state. The finding that levels of SA in individuals recovered from AN lie between that of 
HCs and acutely ill individuals lends further support for this hypothesis (Shmelkin et al. 
2017).  
Importantly, the lack of any association between BMI and SA indicates that it is not the 
degree of malnutrition that exacerbates SA, but some other factor associated with the illness. 
One possible explanation concerns emotional avoidance. Many have theorised that ED 
psychopathology (for example, a focus on food and weight, restrictive behaviours, and binge 
eating) helps individuals avoid having to experience negative emotions and challenging 
interpersonal situations (Slade, 1982). It has been demonstrated that comorbid depressive and 
anxiety symptoms are associated with higher ED psychopathology in AN, and this 
relationship is almost fully mediated by emotional avoidance (Wildes, Ringham, & Marcus, 
2010). Therefore, it could be the case that those with higher social anxiety avoid situations 
that may elicit high emotion through an intense focus on food and weight, therefore 
reinforcing and maintaining the disorder. Further studies examining the relationship between 
SA (rather than general anxiety symptoms) and emotional avoidance are required to test this 
hypothesis.  
Clinical implications 
Findings from the current review contribute to the broader literature on socio-emotional 
functioning in EDs, which have demonstrated problems in areas such as theory of mind (Bora 
& Kose, 2016), emotion expression and recognition (Caglar-Nazali et al. 2014; Davies et al. 
2016), social anhedonia (Harrison et al. 2014), and alexithymia (Westwood et al. 2017a). 
Further, they contribute to a growing evidence base documenting high levels of autism 
spectrum disorder (ASD) traits in those with AN (Westwood et al. 2017b). Like those with 
EDs, individuals with ASD show high levels of SA, with over half of adolescents meeting 
clinical cut-offs on self-report measures (Kuusikko et al. 2008). Because of the high degree 
of symptom overlap between SAD and ASD, it is possible that the high levels of SA 
displayed in EDs are linked to ASD traits. While it may not be possible to delineate the 
unique contributions of SAD and ASD traits to the social difficulties seen in AN and other 
EDs, these difficulties may be useful targets for treatment. For example, there is evidence that 
social skills training in adolescents with EDs may improve self-esteem and social withdrawal 
(Lázaro et al. 2011). In addition, preliminary evidence suggests that Cognitive Remediation 
and Emotion Skills Training (CREST), an intervention designed to target emotion processing, 
decreases social anhedonia and alexithymia in adults with AN (Tchanturia et al. 2015). 
Future research into the influence of SA on outcomes and prognosis is warranted.  
Limitations 
Several limitations of this review should be noted. Firstly, a considerable number of the 
studies included did not report important participant characteristics, such as BMI. Therefore, 
BMI could not be entered as a moderator variable in the meta-analysis. A further limitation is 
that none of the studies included in this review examined SA in EDNOS or OSFED (“not 
otherwise specified” categories in the DSM-IV and DSM-5 respectively) compared to HCs. 
Considering such diagnoses make up a significant proportion of those with EDs (Allen et al. 
2013; Fairweather-Schmidt & Wade, 2014), establishing whether these patients show similar 
social difficulties will have important implications for their treatment. Finally, the number of 
studies that could be included in the meta-analyses (especially for BN studies) was relatively 
few, since the majority of studies did not include a HC group.  
Conclusions 
Both AN and BN are characterised by high levels of SA, even in those who do not have a 
formal diagnosis of SAD. SA in these patients is associated with longer illness duration, older 
age, and higher ED psychopathology, suggesting that SA may be indicative of a more severe 
form of ED. Despite significant reductions following treatment, there is some evidence that 
SA remains elevated in those recovered from AN compared to HCs. Whether SA impacts on 
treatment adherence and outcomes has not yet been examined, but such research may be 
important in improving prognosis for EDs. Furthermore, research in this area may lead to 
new insights into common illness pathways and transdiagnostic factors for AN and other 
disorders, such as ASD or SAD.   
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Study Sample Mean (SD) SA 
score  
Measure Mean age 
(SD) 
Mean BMI 
(SD) 
Mean (yrs) illness 
duration (SD) 
% female Recruitment 
source 
Groups 
matched by 
Abbate Daga et 
al. (2015) 
56 AN Baseline 37.16 
(12.66) 
BSPS 25.03 (5.75) 16.31 (2.66) 7.8 (5.34) 100 Day hospital NA 
  
6 months 26.42 
(9.66) 
       
  
12 months 22.81 
(10.30) 
       
Allen & 
Craighead 
(1999) 
11 BED 
(treatment) 
Pre-treatment 
23.09 (4.11)  
FNE 21 (1.2)a 122.82 
(22.86)% IBW 
NR 100 University 
advertisement  
Sex 
 
Post-treatment 
20.0 (5.0) 
       
9 BED (waitlist) Pre-treatment 
23.11 (9.68)  
  
116.5 
(21.98)% IBW 
NR 100 University 
advertisement  
 
 
Post-treatment 
22.33 (8.66) 
       
Bucholz et al. 
(2007) 
149 ED 15.02 (7.17) MASC 
social 
anxiety 
subscale 
15.65 (1.17) NR NR 100 Tertiary care 
childrens 
hospital  
NA 
Bulik et al. 
(1991) 
23 AN 86.2 (26.4) SPAI 
difference 
scores 
20.3 (8.3) NR NR 100 Inpatient unit Sex 
 
54 BN 84.9 (27.9) 22.4 (6.0) NR NR 100 Inpatient unit 
 
 
43 SAD 98.7 (35.3) 36.3 (9.6) NR NR 100 Social phobia 
clinic  
 
 
50 HC 54.6 (35.9) 18.5 (1.2) NR NA 100 University 
undergraduates 
 
Dakanalis et al. 
(2016) 
189 young 
female 
adolescent ED 
 30.29 (12.61) SIAS 12.59 (0.70)a AN = 15.52 
(1.24), BN = 
21.18 (2.07), 
EDNOS = 
20.05 (3.54) 
NR 100 Specialist child 
and adolescent 
ED service 
NR 
 
37.33 (12.49) SPS 
    
 
39.86 (11.05) BFNE 
    
 
15 young male 
adolescent ED 
29.88 (12.24) SIAS  
 
NR 0 
 
  
32.31 (13.13) SPS 
     
  
32.01 (12.88) BFNE 
      
 
444 older female 
adolescent ED 
37.01 (13.06) SIAS 16.74 (0.61)a 
 
NR 100 
  
 
44.41 (13.88) SPS 
      
 
45.55 (10.55) BFNE 
      
 
55 older male 
adolescent ED 
36.65 (13.32) SIAS  
  
NR 0 
  
  
34.35 (12.96) SPS 
      
  
34.69 (11.11) BFNE  
      
Duclos et al. 
(2014) and 
Courty et al. 
(2015) 
60 AN  Baseline 48.3 
(31.3) 
LSAS 16 (1.6) 16.9 (1.1) 1.38 (0.57) 100 Inpatient unit NA 
 
6 months 33.1 
(27.9) 
       
 
12 months 33.2 
(29.7) 
       
 
18 months 27.2 
(26.3) 
       
Flament et al. 
(2001) 
29 AN-R 50 (10.30) LSAS 17.9 (4.3) NR 2 (3) 93.1 Inpatient unit NR 
34 BN 54 (16.51) 
 
26.6 (6.5) NR 7 (6) 100 Outpatient clinic 
 
Gilboa-
Schectman et al. 
(2006) 
20 AN 73.05 (37.28) LSAS 16.60 (2.48) NR NR 100 Outpatient clinic Age, sex, 
education 
20 BN 58.60 (42.48) 
 
19.65 (5.01) NR NR 100 Outpatient clinic 
 
20 HC 33.90 (18.67) 
 
19.65 (5.01) NR NA 100 Community 
advertisement  
 
Goddard & 
Treasure (2013) 
63 ED 61.6 (31.6) LSAS 21.8 (5.5) 16.8 (2.5) 4.0 (2.0-7.6)b 100 ED clinics Age, sex, 
education, IQ 
50 HC 29.8 (17.8) 
 
21.5 (5.9) 21.1 (2.0) NA 100 University 
advertisement 
 
Grabhorn et al. 
(2006) 
30 AN  33.5 (12.9)  SIAS 25.5 (7.7)  NR NR 100 Inpatient clinic 
referrals 
Sex 
 
29.3 (11.3) SPS 
     
30 BN 39.4 (12.9) SIAS  24.9 (6.8) NR NR 100 
  
 
35.4 (16.2) SPS 
      
30 Depression   30.6 (14.9) SIAS 41.1 (10.9) NR NR 100 
  
  
21.3 (13.0) SPS 
      
 
30 Anxiety  23.6 (14.5)  SIAS 36.9 (12.8) NR NR 100 
  
  
19.5 (18.1) SPS 
      
Gross et al. 
(1988) 
65 BN (female) 9.49 (7.03) SADS NR NR NR 100 Public schools Sex 
 612 HC (female) 6.98 (6.14)  NR NR NA 100  
 8 BN (male) 15.29 (5.9)  NR NR NR 0   
 645 HC (male) 7.69 (4.5)  NR NR NA 0   
Hinrichsen et al. 
(2003) 
21 AN-R 23.5 (8.68) FNE 25.7 (9.06) NR NR 100 Specialist ED 
service 
Sex 
34 AN-BP 26.7 (4.32) 
 
28.0 (6.79) NR NR 100 
 
59 BN 23.6 (6.72) 
 
26.9 (6.56) NR NR 100 
 
50 HC 18.5 (6.97) 
 
19.8 (0.86) NR NA 100 University 
undergraduates 
 
Hinrichsen et al. 
(2004a); 
(2004b); (2007a) 
70 ED 88.41 (35.10) SPAI 
social 
phobia 
subscale 
27.9 (8.76) 22.9 (11.53) NR 100 Specialist ED 
service referrals 
(outpatient) 
NA 
Hinrichsen et al. 
(2007b) 
191 ED 27.4 (7.84) BFNE 28.4 (8.62) 20.4 (6.77) NR 100 Specialist ED 
service 
NA 
Jimenez-Murcia 
et al. (2015) 
50 BN 13.7 (8.50) SADS 28.1 (8.2) NR NR 100 Psychiatric 
department 
referrals 
Sex 
 
49 BN + 
compulsive 
buying 
15.7 (7.64)  
 
26.9 (9.1) NR NR 100 
 
MacDonald et al. 
(2014) 
171 BN 30.26 (14.66) SPIN 26.2 (8.2) 22.7 (5.33) 9.2 (8.2) 96.5 Day hospital NA 
Mattar et al. 
(2012a) 
155 AN 57.73 (15.85) LSAS 20.90 (6.16) 14.43 (1.46) 4.29 (4.71)  100 Inpatient unit NA 
Mattar et al. 
(2012b) 
24 AN-R Baseline 47.05 
(28.30) 
LSAS 16.38 (1.93) 13.84 (1.26) 0.98 (0.82)  100 Inpatient unit NA 
  
EOT 24.95 (26.91) 
       
McFarlane et al. 
(2015) 
299 ED 31.5 (15.1) SPIN 26.0 (7.8) 17.1 (1.0) 8.3 (7.3) 97 Day hospital NR 
 
130 ED 33.9 (15.5) 
 
30.9 (11.1) 17.0 (1.0) 14.4 (11.2) 96.8 
  
Melfsen et al. 
(2006) 
48 AN  15.35 (9.25) SPAI-C NR NR NR NR Child and 
adolescent 
psychiatric 
departments  
NR 
 
31 SAD  29.59 (9.79) 
 
12.19 (2.59) NR NR 58.1 
 
 
7 AS 20.77 (13.77) 
 
15.71 (2.5) NR NR 28.6 
 
 
1197 HC 12.51 (7.87) 
 
12.51 (2.05) NR NA 51.5 NR 
 
Obeid et al. 
(2013) 
182 AN-R or 
EDNOS-R 
14.49 (7.32)c, 14.2 
(7.19)d 
MASC 
social 
anxiety 
subscale 
15.6 (1.39) 17.02 (2.27)c, 
17.05 (2.14)d 
NR 100 Children’s 
tertiary care 
facility  
Sex 
 
99 AN-BP or 
EDNOS-BP 
15.21 (6.04)c, 
16.14 (6.94)d 
 
20.55 (3.50)c, 
19.94 (3.71)d 
NR 100 
 
 
63 BN 19.89 (5.71)c, 
14.08 (6.78)d 
 
22.02 (2.62)c, 
22.30 (3.79)d 
NR 100 
 
Ostrovsky et al. 
(2013) 
29 BED 50.3e SPIN 36.0 (12.8)a 33.7 (6.7)a NR 86.8a Online and 
university 
advertisements  
NR 
 
202 HC  32.6e 
   
NA 
  
Ohmann et al. 
(2013)f 
29 AN  Baseline 24.1 (9.1) SIAS 14.3e 15.7 (1.3) 0.6e 100 Inpatient unit NA 
  Baseline 15.4 (9.9) SPS       
  9 months 26.7 
(14.3) 
SIAS  17.8 (1.7)     
  9 months 14.6 
(15.0) 
SPS       
Russell et al. 
(2018) 
16 AN (oxytocin) Baseline 59.4 
(29.1) 
LSAS 22.4 (3.6) 16.61  (1.77) NR 100 Inpatient unit Sex 
  Follow-up 59.4 
(28.9) 
  18.00 (1.86)     
 17 AN (placebo) Baseline 63.1 
(24.4) 
 23.5 (10.2) 16.75 (1.36) NR 100   
  Follow-up 58.4 
(27.3) 
  18.10 (1.29)     
Sawaoka et al. 
(2012) 
113 BED 15.13 (4.51) SCS 
social 
anxiety 
subscale 
45.03 (8.30) 37.1 (7.3) NR 77.9 Newspaper 
advertisements 
NA 
Schmelkin et al. 
(2017) 
19 AN 61.95 (30.53) LSAS 25.1 (1.7) 17.7 (0.2) NR 100 Community Sex 
 
23 AN-WR 36.74 (19.15) 
 
22.9 (.5) 22.5 (0.4) NR 100 
  
 
28 HC 22.25 (15.68) 
 
23.9 (.8) 22.6 (0.3) NA 100 
  
Schneier et al. 
(2016) 
30 AN 54.1 (26.1) LSAS 26.9(7.5) NR NR 97 Media notices 
and referrals 
from health 
professionals 
NR 
 
43 SAD 76.4 (19.8) 
 
29.9 (7.5) NR NR 53 
 
 
50 OCD 24.2 (16.7) 
 
29.2 (5.9) NR NR 50 
 
 
74 HC 11.5 (8.0) 
 
28.9 (7.6) NR NA 51 
 
Schultz et al. 
(2009) 
23 AN 17.4 (9.7) SPAI-C 14.69 (1.54) 14.7 (1.58) NR 100 Inpatients at a 
child and 
adolescent 
psychiatric 
department 
NR 
 
145 PC 16.52 (10.77) 
 
13.29 (2.86) NR NR NR NR 
 
 
1197 HC 12.51 (7.87) 
 
12.51 (2.05) NR NA 51.5 NR 
 
Schwalberg et 
al. (1992) 
20 BN 14.7 (5.9) SCS 
social 
anxiety 
subscale 
26.35 (6.44) 104.5 (12.5)% 
IBW 
NR 100 ED clinics Sex 
20 BED 15.1 (5.6) 41.18 (7.66) 157.9 (31.8)% 
IBW 
NR 100 
 
20 SAD 19.6 (3.7) 34.70 (9.74) NR NR 100 Anxiety disorder 
clinics 
 
20 PD 13.9 (6.1) 31.50 (6.90)  NR NA 100 
 
Solano et al. 
(2005) 
35 AN & BN (SI)  19.41 (6.79) SADS 22.31 (4.46) 18.85 (4.12) 4.83 (3.69) 100 Outpatient clinic Sex 
 
74 AN & BN (no 
SI) 
15.09 (9.05) 
 
23.24 (6.08) 19.43 (4.70)  5.82 (5.74) 100 
  
Steinglass et al. 
(2017) 
27 AN 52.44 (23.07) LSAS 27.7 (7.5) 17.5 (1.0) NR 100 Inpatient unit Age, sex, 
ethnicity  
44 SAD 75.72 (20.05) 
 
30.0 (4) 23.9 (6.3) NR 57 Outpatient clinic 
 
 
50 OCD 24.18 (16.66) 
 
29.2 (5.8) 24.6 (5.3) NR 48 Outpatient clinic 
 
 
75 HC 11.39 (7.96) 
 
29.0 (7.6) 24.1 (4.4) NA 52 NR 
 
Steinman et al. 
(2016) 
26 AN 47.81 (20.14) LSAS 26.93 (7.67) NR NR 100 Inpatients NR 
 37 SAD 75.00 (19.32)  28.54 (6.66) NR NR 59 Media and 
referrals from 
health 
professionals 
 
 45 OCD 23.04 (17.03)  28.80 (5.89) NR NR 47  
 62 HC 12.42 (8.01)  27.60 (6.50) NR NA 53  
Striegel-Moore 
et al. (1993) 
34 BN 19.71 (5.39) SCS 
social 
anxiety 
subscale 
23.36 (5.8)a 21.64 (2.76) 6.8 (4.15) 100 ED clinics Age, sex, 
ethnicity, BMI  
33 sub-clinical 
ED 
19.24 (4.49) 
 
22.47 (2.92) NA 100 University 
undergraduates 
and newspaper 
advertisments  
 
 
67 HC 15.01 (5.0) 
  
22.08 (2.87) NA 100 
 
Zonnevylle-
Bender et al. 
(2004) 
23 adult AN 108.6 (41.4) SPAI 
social 
phobia 
subscale 
21.3 (3.1) 15.7 (1.4) NR NR Inpatient eating 
disorder clinic  
NR 
 
48 adolescent 
AN 
80 (31.4) 15.5 (1.1) 14.8 (3.3) NR NR Inpatients or 
outpatients at a 
child and 
adolescent 
eating disorder 
clinic 
 
Zonnevylle-
Bender et al. 
(2005) 
10 AN-R 103.6 (37.6) SPAI 
social 
phobia 
subscale 
15.5 (1.8) 16.2 (1.2)  0.92 100 NR Age, sex, 
education 
 
22 HC 68.09 (25.1) 14.9 (1.1) NR NA 100 High school 
 
AN, anorexia nervosa; AN-BP, anorexia nervosa binge-purge sub-type; AN-R, anorexia nervosa restricting sub-type; AN-WR, anorexia nervosa weight restored; AS, Asperger’s syndrome; 
BED, binge eating disorder; BFNE, Brief Fear of Negative Evaluation scale; BMI, body mass index; BN, bulimia nervosa; BSPS, brief social phobia scale; ED, eating disorder; EDNOS, 
eating disorder not otherwise specified; FNE, Fear of Negative Evaluation scale; HC, healthy control; IBW, ideal body weight; IQ, intelligence quotient; LSAS, Liebowitz Social Anxiety 
Scale; MASC, Multidimensional Anxiety Scale for Children; NA, not applicable; NR, not reported; OCD, obsessive compulsive disorder; PC, psychiatric control; PD, panic disorder; SAD, 
social anxiety disorder; SADS, Social Avoidance and Distress Scale; SA, social anxiety; SCS, Self-Consciousness Scale; SD, standard deviation; SI, self-injury;  SIAS, Social Interaction 
Anxiety Scale; SPAI, Social Phobia & Anxiety Inventory;  SPAI-C, Social Phobia & Anxiety Inventory for Children; SPIN, Social Phobia Inventory; SPS, Social Phobia Scale 
aValues reported for groups combined 
bMedian and inter-quartile range 
cMid-adolescents  
dLate-adolescents 
eNo SD reported 
fFour additional follow-up periods included in paper excluded here for brevity  
 
 Figure 1. Systematic review search process.  
 
 
 
 Figure 2. Forest plot of standardized mean effect size for differences (SMD) between 
anorexia nervosa (AN) and healthy controls (HC). CI, confidence interval; FNE, Fear of 
Negative Evaluation scale; LSAS, Liebowitz Social Anxiety Scale; SPAI, Social Phobia & 
Anxiety Inventory; SPAI-C, Social Phobia & Anxiety Inventory for Children  
 
 
 Figure 3. Funnel plot of anorexia nervosa (AN) studies included in the meta-analysis to 
assess publication bias.  
 
 Figure 4. Forest plot of standardized mean effect size for differences (SMD) between 
bulimia nervosa (BN) and healthy controls (HC). CI, confidence interval; FNE, Fear of 
Negative Evaluation scale; LSAS, Liebowitz Social Anxiety Scale; SADS, Social Anxiety 
and Distress Scale; SCS, Self-Consciousness Scale; SPAI, Social Phobia & Anxiety 
Inventory 
 
 
 Figure 5. Funnel plot of bulimia nervosa (BN) studies included in the meta-analysis to assess 
publication bias. 
 
